查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
神经胶质瘤(神经胶质瘤)治疗的全球市场:产业分析，规模，占有率，成长，趋势，预测(2022年～2031年)
市场调查报告书
商品编码
1121687

神经胶质瘤(神经胶质瘤)治疗的全球市场:产业分析，规模，占有率，成长，趋势，预测(2022年～2031年)

Glioma Treatment Market (Type: Low-grade and High-grade) - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2022-2031
出版日期: | 出版商: Transparency Market Research | 英文 163 Pages | 商品交期: 2-10个工作天内

价格

本报告提供全球神经胶质瘤(神经胶质瘤)治疗市场相关调查分析，市场促进因素和阻碍因素，洞察，各市场区隔的分析与预测，各地区分析，企业简介等资讯。

目录

第1章 序文

第2章 前提与调查手法

第3章 摘要整理:全球神经胶质瘤(神经胶质瘤)治疗市场

第4章 市场概要

  • 简介
    • 定义
    • 产业的演进/发展
  • 概要
  • 市场动态
    • 促进因素
    • 阻碍因素
    • 机会
  • 全球神经胶质瘤(神经胶质瘤)治疗市场分析与预测(2017年～2031年)

第5章 主要洞察

  • 主要的产业活动(合併和收购，产品销售，伙伴关係)
  • 开发平台分析
  • 低恶性度神经胶质瘤(神经胶质瘤):概要
  • 全球盛行率、发病率
  • COVID-19流行对产业的影响

第6章 全球神经胶质瘤(神经胶质瘤)治疗市场分析与预测:各类型

  • 简介和定义
  • 主要调查结果/开发
  • 市场价值预测:各类型(2017年～2031年)
    • 低恶性度
    • 高恶性度
  • 市场魅力:各类型

第7章 全球神经胶质瘤(神经胶质瘤)治疗市场分析与预测:各治疗法

  • 简介和定义
  • 主要调查结果/开发
  • 市场价值预测:各治疗法(2017年～2031年)
    • 手术
    • 放射治疗
    • 化疗
    • 标的药物疗法
    • 其他
  • 市场魅力:各治疗法

第8章 全球神经胶质瘤(神经胶质瘤)治疗市场分析与预测:各地区

  • 主要调查结果
  • 市场价值预测:各地区
    • 北美
    • 欧洲
    • 亚太地区
    • 南美
    • 中东、非洲
  • 市场魅力:各地区

第9章 北美的神经胶质瘤(神经胶质瘤)治疗市场分析与预测

  • 简介
    • 主要调查结果
  • 市场价值预测:各类型(2017年～2031年)
    • 低恶性度
    • 高恶性度
  • 市场价值预测:各治疗法(2017年～2031年)
    • 手术
    • 放射治疗
    • 化疗
    • 标的药物疗法
    • 其他
  • 市场价值预测:各国(2017年～2031年)
    • 美国
    • 加拿大
  • 市场魅力分析
    • 各类型
    • 各治疗法
    • 各国

第10章 欧洲的神经胶质瘤(神经胶质瘤)治疗市场分析与预测

第11章 亚太地区的神经胶质瘤(神经胶质瘤)治疗市场分析与预测

第12章 南美的神经胶质瘤(神经胶质瘤)治疗市场分析与预测

第13章 中东、非洲的神经胶质瘤(神经胶质瘤)治疗市场分析与预测

第14章 竞争情形

  • 市场参与者 - 竞争矩阵(阶层、各企业规模)
  • 市场占有率分析:各企业(2021年)
  • 企业简介
    • Bristol-Myers Squibb Company
    • Genentech, Inc. (F. Hoffmann-La Roche Ltd.)
    • Pfizer, Inc.
    • Merck & Co., Inc
    • Teva Pharmaceutical Industries Ltd
    • Sun Pharmaceutical Industries Ltd.
    • Amgen, Inc.
    • 其他的有名企业
Product Code: TMRGL84872

The report provides revenue of the global glioma treatment market for the period 2017-2031, considering 2021 as the base year and 2031 as the forecast year. The report also provides the compound annual growth rate (CAGR %) of the global glioma treatment market from 2022 to 2031.

The report has been prepared after an extensive research. Primary research involved bulk of the research efforts, wherein analysts carried out interviews with key opinion leaders, industry leaders, and opinion makers. Secondary research involved referring to key players' product literature, annual reports, press releases, and relevant documents to understand the glioma treatment market.

The report delves into the competitive landscape of the global glioma treatment market. Key players operating in the global glioma treatment market have been identified and each one of these has been profiled, in terms of various attributes. Company overview, financial standings, recent developments, and SWOT are attributes of players in the global glioma treatment market profiled in this report.

Table of Contents

1. Preface

  • 1.1. Market Definition and Scope
  • 1.2. Market Segmentation
  • 1.3. Key Research Objectives
  • 1.4. Research Highlights

2. Assumptions and Research Methodology

3. Executive Summary : Global Glioma Treatment Market

4. Market Overview

  • 4.1. Introduction
    • 4.1.1. Definition
    • 4.1.2. Industry Evolution / Developments
  • 4.2. Overview
  • 4.3. Market Dynamics
    • 4.3.1. Drivers
    • 4.3.2. Restraints
    • 4.3.3. Opportunities
  • 4.4. Global Glioma Treatment Market Analysis and Forecasts, 2017-2031

5. Key Insights

  • 5.1. Key Industry Events (Mergers & Acquisitions, Product Launches, Partnerships)
  • 5.2. Pipeline Analysis
  • 5.3. Low Grade Glioma: Overview
  • 5.4. Disease Prevalence Rate & Incidence Rate Globally
  • 5.5. Covid-19 Pandemic Impact on the Industry

6. Global Glioma Treatment Market Analysis and Forecast, by Type

  • 6.1. Introduction & Definition
  • 6.2. Key Findings / Developments
  • 6.3. Market Value Forecast, by Type, 2017-2031
    • 6.3.1. Low-Grade
      • 6.3.1.1. grade I
      • 6.3.1.2. grade II
    • 6.3.2. High-grade
      • 6.3.2.1. grade III
      • 6.3.2.2. grade IV
  • 6.4. Market Attractiveness, by Type

7. Global Glioma Treatment Market Analysis and Forecast, by Treatment

  • 7.1. Introduction & Definition
  • 7.2. Key Findings / Developments
  • 7.3. Market Value Forecast, by Treatment, 2017-2031
    • 7.3.1. Surgery
    • 7.3.2. Radiation Therapy
    • 7.3.3. Chemotherapy
    • 7.3.4. Targeted Drug Therapy
    • 7.3.5. Others
  • 7.4. Market Attractiveness, by Treatment

8. Global Glioma Treatment Market Analysis and Forecast, by Region

  • 8.1. Key Findings
  • 8.2. Market Value Forecast, by Region
    • 8.2.1. North America
    • 8.2.2. Europe
    • 8.2.3. Asia Pacific
    • 8.2.4. Latin America
    • 8.2.5. Middle East & Africa
  • 8.3. Market Attractiveness, by Region

9. North America Glioma Treatment Market Analysis and Forecast

  • 9.1. Introduction
    • 9.1.1. Key Findings
  • 9.2. Market Value Forecast, by Type, 2017-2031
    • 9.2.1. Low-Grade
      • 9.2.1.1. grade I
      • 9.2.1.2. grade II
    • 9.2.2. High-grade
      • 9.2.2.1. grade III
      • 9.2.2.2. grade IV
  • 9.3. Market Value Forecast, by Treatment, 2017-2031
    • 9.3.1. Surgery
    • 9.3.2. Radiation Therapy
    • 9.3.3. Chemotherapy
    • 9.3.4. Targeted Drug Therapy
    • 9.3.5. Others
  • 9.4. Market Value Forecast, by Country, 2017-2031
    • 9.4.1. U.S.
    • 9.4.2. Canada
  • 9.5. Market Attractiveness Analysis
    • 9.5.1. By Type
    • 9.5.2. By Treatment
    • 9.5.3. By Country

10. Europe Glioma Treatment Market Analysis and Forecast

  • 10.1. Introduction
    • 10.1.1. Key Findings
  • 10.2. Market Value Forecast, by Type, 2017-2031
    • 10.2.1. Low-Grade
      • 10.2.1.1. grade I
      • 10.2.1.2. grade II
    • 10.2.2. High-grade
      • 10.2.2.1. grade III
      • 10.2.2.2. grade IV
  • 10.3. Market Value Forecast, by Treatment, 2017-2031
    • 10.3.1. Surgery
    • 10.3.2. Radiation Therapy
    • 10.3.3. Chemotherapy
    • 10.3.4. Targeted Drug Therapy
    • 10.3.5. Others
  • 10.4. Market Value Forecast, by Country/Sub-region, 2017-2031
    • 10.4.1. Germany
    • 10.4.2. U.K.
    • 10.4.3. France
    • 10.4.4. Italy
    • 10.4.5. Spain
    • 10.4.6. Rest of Europe
  • 10.5. Market Attractiveness Analysis
    • 10.5.1. By Type
    • 10.5.2. By Treatment
    • 10.5.3. By Country/Sub-region

11. Asia Pacific Glioma Treatment Market Analysis and Forecast

  • 11.1. Introduction
    • 11.1.1. Key Findings
  • 11.2. Market Value Forecast, by Type, 2017-2031
    • 11.2.1. Low-Grade
      • 11.2.1.1. grade I
      • 11.2.1.2. grade II
    • 11.2.2. High-grade
      • 11.2.2.1. grade III
      • 11.2.2.2. grade IV
  • 11.3. Market Value Forecast, by Treatment, 2017-2031
    • 11.3.1. Surgery
    • 11.3.2. Radiation Therapy
    • 11.3.3. Chemotherapy
    • 11.3.4. Targeted Drug Therapy
    • 11.3.5. Others
  • 11.4. Market Value Forecast, by Country/Sub-region, 2017-2031
    • 11.4.1. China
    • 11.4.2. Japan
    • 11.4.3. India
    • 11.4.4. Australia & New Zealand
    • 11.4.5. Rest of Asia Pacific
  • 11.5. Market Attractiveness Analysis
    • 11.5.1. By Type
    • 11.5.2. By Treatment
    • 11.5.3. By Country/Sub-region

12. Latin America Glioma Treatment Market Analysis and Forecast

  • 12.1. Introduction
    • 12.1.1. Key Findings
  • 12.2. Market Value Forecast, by Type, 2017-2031
    • 12.2.1. Low-Grade
      • 12.2.1.1. grade I
      • 12.2.1.2. grade II
    • 12.2.2. High-grade
      • 12.2.2.1. grade III
      • 12.2.2.2. grade IV
  • 12.3. Market Value Forecast, by Treatment, 2017-2031
    • 12.3.1. Surgery
    • 12.3.2. Radiation Therapy
    • 12.3.3. Chemotherapy
    • 12.3.4. Targeted Drug Therapy
    • 12.3.5. Others
  • 12.4. Market Value Forecast, by Country/Sub-region, 2017-2031
    • 12.4.1. Brazil
    • 12.4.2. Mexico
    • 12.4.3. Rest of Latin America
  • 12.5. Market Attractiveness Analysis
    • 12.5.1. By Type
    • 12.5.2. By Treatment
    • 12.5.3. By Country/Sub-region

13. Middle East & Africa Glioma Treatment Market Analysis and Forecast

  • 13.1. Introduction
    • 13.1.1. Key Findings
  • 13.2. Market Value Forecast, by Type, 2017-2031
    • 13.2.1. Low-Grade
      • 13.2.1.1. grade I
      • 13.2.1.2. grade II
    • 13.2.2. High-grade
      • 13.2.2.1. grade III
      • 13.2.2.2. grade IV
  • 13.3. Market Value Forecast, by Treatment, 2017-2031
    • 13.3.1. Surgery
    • 13.3.2. Radiation Therapy
    • 13.3.3. Chemotherapy
    • 13.3.4. Targeted Drug Therapy
    • 13.3.5. Others
  • 13.4. Market Value Forecast, by Country/Sub-region, 2017-2031
    • 13.4.1. GCC Countries
    • 13.4.2. South Africa
    • 13.4.3. Rest of Middle East & Africa
  • 13.5. Market Attractiveness Analysis
    • 13.5.1. By Type
    • 13.5.2. By Treatment
    • 13.5.3. By Country/Sub-region

14. Competition Landscape

  • 14.1. Market Player - Competition Matrix (By Tier and Size of companies)
  • 14.2. Market Share Analysis By Company (2021)
  • 14.3. Company Profiles
    • 14.3.1. Bristol-Myers Squibb Company
      • 14.3.1.1. Company Overview
      • 14.3.1.2. Company Financials
      • 14.3.1.3. Growth Strategies
      • 14.3.1.4. SWOT Analysis
    • 14.3.2. Genentech, Inc. (F. Hoffmann-La Roche Ltd.
      • 14.3.2.1. Company Overview
      • 14.3.2.2. Company Financials
      • 14.3.2.3. Growth Strategies
      • 14.3.2.4. SWOT Analysis
    • 14.3.3. Pfizer, Inc.
      • 14.3.3.1. Company Overview
      • 14.3.3.2. Company Financials
      • 14.3.3.3. Growth Strategies
      • 14.3.3.4. SWOT Analysis
    • 14.3.4. Merck & Co., Inc
      • 14.3.4.1. Company Overview
      • 14.3.4.2. Company Financials
      • 14.3.4.3. Growth Strategies
      • 14.3.4.4. SWOT Analysis
    • 14.3.5. Teva Pharmaceutical Industries Ltd
      • 14.3.5.1. Company Overview
      • 14.3.5.2. Company Financials
      • 14.3.5.3. Growth Strategies
      • 14.3.5.4. SWOT Analysis
    • 14.3.6. Sun Pharmaceutical Industries Ltd.
      • 14.3.6.1. Company Overview
      • 14.3.6.2. Company Financials
      • 14.3.6.3. Growth Strategies
      • 14.3.6.4. SWOT Analysis
    • 14.3.7. Amgen, Inc.
      • 14.3.7.1. Company Overview
      • 14.3.7.2. Company Financials
      • 14.3.7.3. Growth Strategies
      • 14.3.7.4. SWOT Analysis
    • 14.3.8. Other prominent players
      • 14.3.8.1. Company Overview
      • 14.3.8.2. Company Financials
      • 14.3.8.3. Growth Strategies
      • 14.3.8.4. SWOT Analysis

List of Tables

  • Table 01: Global Glioma Treatment Market Value (US$ Mn) Forecasts, by Type, 2017-2031
  • Table 02: Global Glioma Treatment Market Value (US$ Mn) Forecast, by High-grade, 2017-2031
  • Table 03: Global Glioma Treatment Market Value (US$ Mn) Forecast, by Low-grade , 2017-2031
  • Table 04: Global Glioma Treatment Market Value (US$ Mn) Forecast, by Treatment, 2017-2031
  • Table 05: Global Glioma Treatment Market Value (US$ Mn) Forecast, by Region, 2017-2031
  • Table 06: North America Glioma Treatment Market Value (US$ Mn) Forecast, by Country, 2017-2031
  • Table 07: North America Glioma Treatment Market Value (US$ Mn) Forecast, by Type, 2017-2031
  • Table 08: North America Glioma Treatment Market Value (US$ Mn) Forecast, by High-grade, 2017-2031
  • Table 09: North America Glioma Treatment Market Value (US$ Mn) Forecast, by Low-grade, 2017-2031
  • Table 10: North America Glioma Treatment Market Value (US$ Mn) Forecast, by Treatment, 2017-2031
  • Table 11: Europe Glioma Treatment Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017-2031
  • Table 12: Europe Glioma Treatment Market Value (US$ Mn) Forecast, by Type, 2017-2031
  • Table 13: Europe Glioma Treatment Market Value (US$ Mn) Forecast, by High-grade, 2017-2031
  • Table 14: Europe Glioma Treatment Market Value (US$ Mn) Forecast, by Low-grade, 2017-2031
  • Table 15: Europe Glioma Treatment Market Value (US$ Mn) Forecast, by Treatment, 2017-2031
  • Table 16: Asia Pacific Glioma Treatment Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017-2031
  • Table 17: Asia Pacific Glioma Treatment Market Value (US$ Mn) Forecast, by Type, 2017-2031
  • Table 18: Asia Pacific Glioma Treatment Market Analysis and Value (US$ Mn) Forecast, by High-grade, 2017-2031
  • Table 19: Asia Pacific Glioma Treatment Market Value (US$ Mn) Forecast, by Low-grade, 2017-2031
  • Table 20: Asia Pacific Glioma Treatment Market Value (US$ Mn) Forecast, by Treatment, 2017-2031
  • Table 21: Latin America Glioma Treatment Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017-2031
  • Table 22: Latin America Glioma Treatment Market Value (US$ Mn) Forecast, by Type, 2017-2031
  • Table 23: Latin America Glioma Treatment Market and Value (US$ Mn) Forecast, by High-grade, 2017-2031
  • Table 24: Latin-America Glioma Treatment Market Value (US$ Mn) Forecast, by Low-grade , 2017-2031
  • Table 25: Latin America Glioma Treatment Market Value (US$ Mn) Forecast, by Treatment, 2017-2031
  • Table 26: Middle East & Africa Glioma Treatment Market Analysis and Forecast, by Country/Sub-region, 2017-2031
  • Table 27: Middle East & Africa Glioma Treatment Market Analysis and Forecast, by Type, 2017-2031
  • Table 28: Middle East & Africa Glioma Treatment Market Analysis and Forecast, by High-grade, 2017-2031
  • Table 29: Middle East & Africa Glioma Treatment Market Analysis and Forecast, by Low-grade, 2017-2031
  • Table 30: Middle East & Africa Glioma Treatment Market Analysis and Forecast, by Treatment, 2017-2031

List of Figures

  • Figure 01: Global Glioma Treatment Market Value (US$ Mn) Forecast, 2017-2031
  • Figure 02: Global Glioma Treatment Market Value Share, by Type, 2021
  • Figure 03: Global Glioma Treatment Market Value Share, by Treatment, 2021
  • Figure 04: Global Glioma Treatment Market Value Share, by Region, 2021
  • Figure 05: 5-year Relative Survival Rate
  • Figure 06: Global Glioma Treatment Market, by Type, 2021 and 2031
  • Figure 07: Global Glioma Treatment Market Attractiveness Analysis, by Type, 2022-2031
  • Figure 08: Global Glioma Treatment Market (US$ Mn), by High-grade, 2017-2031
  • Figure 09: Global Glioma Treatment Market (US$ Mn), by Low-grade , 2017-2031
  • Figure 10: Global Glioma Treatment Market, by Treatment, 2021 and 2031
  • Figure 11: Global Glioma Treatment Market Attractiveness Analysis, by Treatment, 2022-2031
  • Figure 12: Global Glioma Treatment Market (US$ Mn), by Surgery, 2017-2031
  • Figure 13: Global Glioma Treatment Market (US$ Mn), by Radiation Therapy , 2017-2031
  • Figure 14: Global Glioma Treatment Market (US$ Mn), by Chemotherapy, 2017-2031
  • Figure 15: Global Glioma Treatment Market (US$ Mn), by Targeted Drug therapy, 2017-2031
  • Figure 16: Global Glioma Treatment Market (US$ Mn), by Others, 2017-2031
  • Figure 17: Global Glioma Treatment Market, by Region, 2021 and 2031
  • Figure 18: Global Glioma Treatment Market Attractiveness Analysis, by Region, 2022-2031
  • Figure 19: North America Glioma Treatment Market Value (US$ Mn) Forecast, 2017-2031
  • Figure 20: North America Glioma Treatment Market, By Country, 2021 And 2031
  • Figure 21: North America Glioma Treatment Market Attractiveness Analysis, by Country, 2022-2031
  • Figure 22: North America Glioma Treatment Market, by Type, 2021 and 2031
  • Figure 23: North America Glioma Treatment Market Attractiveness Analysis, by Type, 2022-2031
  • Figure 24: North America Glioma Treatment Market, by Treatment, 2021 and 2031
  • Figure 25: North America Glioma Treatment Market Attractiveness Analysis, by Treatment, 2022-2031
  • Figure 26: Europe Glioma Treatment Market Value (US$ Mn) Forecast, 2017-2031
  • Figure 27: Europe Glioma Treatment Market, by Country/Sub-region, 2021 and 2031
  • Figure 28: Europe Glioma Treatment Market Attractiveness Analysis, by Country/Sub-region, 2022-2031
  • Figure 29: Europe Glioma Treatment Market, by Type, 2021 and 2031
  • Figure 30: Europe Glioma Treatment Market Attractiveness Analysis, by Type, 2022-2031
  • Figure 31: Europe Glioma Treatment Market, by Treatment, 2021 and 2031
  • Figure 32: Europe Glioma Treatment Market Attractiveness Analysis, by Treatment, 2022-2031
  • Figure 33: Asia Pacific Glioma Treatment Market Value (US$ Mn) Forecast, 2017-2031
  • Figure 34: Asia Pacific Glioma Treatment Market, by Country/Sub-region, 2021 and 2031
  • Figure 35: Asia Pacific Glioma Treatment Market Attractiveness Analysis, by Country/Sub-region, 2022-2031
  • Figure 36: Asia Pacific Glioma Treatment Market, by Type, 2021 and 2031
  • Figure 37: Asia Pacific Glioma Treatment Market Attractiveness Analysis, by Type, 2022-2031
  • Figure 38:Asia Pacific Glioma Treatment Market, by Treatment, 2021 and 2031
  • Figure 39: Asia Pacific Glioma Treatment Market Attractiveness Analysis, by Treatment, 2022-2031
  • Figure 40: Latin America Glioma Treatment Market Value (US$ Mn) Forecast, 2017-2031
  • Figure 41: Latin America Treatment Market, by Country/Sub-region, 2021 and 2031
  • Figure 42: Latin America Treatment Market Attractiveness Analysis, by Country/Sub-region, 2022-2031
  • Figure 43: Latin America Glioma Treatment Market, by Type, 2021 and 2031
  • Figure 44: Latin America Glioma Treatment Market Attractiveness Analysis, by Type, 2022-2031
  • Figure 45: Latin America Glioma Treatment Market, by Treatment, 2021 and 2031
  • Figure 46: Latin America Glioma Treatment Market Attractiveness Analysis, by Treatment, 2022-2031
  • Figure 47: Middle East & Africa Glioma Treatment Market Analysis, Value (US$ Mn) Forecast, 2017-2031
  • Figure 48: Middle East & Africa Glioma Treatment Market Analysis and Forecast, 2021 and 2031
  • Figure 49: Middle East & Africa Glioma Treatment Market Analysis and Forecast, by Country/Sub-region, 2022-2031
  • Figure 50: Middle East & Africa Glioma Treatment Market Analysis and Forecast, by Type, 2021 and 2031
  • Figure 51: Middle East & Africa Glioma Treatment Market Analysis and Forecast, by Type, 2022-2031
  • Figure 52: Middle East & Africa Glioma Treatment Market Analysis and Forecast, by Treatment, 2021-2031
  • Figure 53: Middle East & Africa Glioma Treatment Market Analysis and Forecast, by Treatment, 2022-2031
  • Figure 54: Global Glioma Treatment Market Share Analysis/Ranking, by Company, 2021